ライフサイエンスコーパス: definite

1 ful when the diagnosis of sarcoidosis is not definite.

2 of sudden unexpected death in epilepsy (two definite, 10 probable; eight males), acquired 2 years [m

3 7 cases of latent RHD: 164 borderline and 63 definite (42 mild, 21 moderate/severe).

4 d 32 (51.6%) had a drug-induced etiology (27 definite, 5 possible).

5 Of the remainder 602 cases, 76 were definite, 54 highly probable, 181 moderately probable, a

6 Stent thrombosis rates were low: definite (7 of 697 [1.0%] vs 4 of 694 [0.6%]; P = .37) a

7 both definite fungus (kappa: 0.88-0.95) and definite Acanthamoeba classification (kappa: 0.63-0.90).

8 0.88 for definite fungus; kappa was 0.72 for definite Acanthamoeba.

9 efinite or probable scaffold thromboses (one definite acute, one definite sub-acute, and one probable

10 mal anatomical structures in few images is a definite advantage.

11 ossible, probable (laboratory supported), or definite ALS according to the revised El Escorial criter

12 obable prion disease and 100 patients with a definite alternative diagnosis, we compared the performa

13 ith suspected AMI and a prognostic cohort of definite AMI patients.

14 Four members were diagnosed with definite and 1 with probable dopa-responsive dystonia.

15 We identified 5 definite and 17 probable healthcare-associated LD cases;

16 Children with mild definite and borderline RHD showed 26% and 9.8% echocard

17 e InterGrowth standard) and for one third of definite and probable cases there was no history of a ra

18 For the Strasbourg criteria, sensitivity for definite and probable diagnosis was 81% and 93%, respect

19 LAM LFA had a sensitivity of 50% for definite and probable histopathological TBM, ELISA a sen

20 Study end points were definite and probable stent thrombosis (ST), clinically

21 c Cardiomyopathy Treatment Evaluation Trial (DEFINITE), and the Sudden Cardiac Death in Heart Failure

22 timate hazard ratios for incident CVD (first definite angina, probable angina followed by revasculari

23 oimmune encephalitis (possible, probable, or definite) are achieved, which can lead to prompt immunot

24 Definite ARVC or post-inflammatory cardiomyopathy was di

25 Eleven of the 23 patients (48%) with definite ARVC would not have been in this group if CMR h

26 Clinical events committee-adjudicated definite AST (occurring </=24 hours after percutaneous c

27 An increased risk of definite AST was associated with shorter than with longe

28 ce of the RNA signature was evaluated in the definite bacterial and viral group and in the indetermin

29 Definite bacterial and viral infection was confirmed by

30 RNA expression signatures distinguishing definite bacterial from viral infection were identified

31 23 patients with microbiologically confirmed definite bacterial infection were classified as bacteria

32 fter microbiological investigation as having definite bacterial infection, definite viral infection,

33 n age, 19 months; 62% male) included 52 with definite bacterial infection, of whom 36 (69%) required

34 the validation group (130 children, with 23 definite bacterial, 28 definite viral, and 79 indetermin

35 ACA was the only ANA that demonstrated a definite bimodal distribution of levels.

36 series of patients treated in our center for definite bioresorbable scaffold thrombosis.

37 rate vitritis and retinal vasculitis without definite birdshot lesions on clinical examination evalua

38 2 (23%), 37 (26%), and 50 (35%) patients had definite, borderline, possible, and no ARVC, respectivel

39 changed categories over time to probable or definite BVFTD and showed progression on cognitive and f

40 classified as having possible, probable, or definite BVFTD at presentation and latest review.

41 Up to June 2014, 14 patients presented with definite BVS thrombosis in our center.

42 assification as pathologically or clinically definite by MRC criteria was required for inclusion body

43 robable AMR and to compare these to cases of definite (C4d-positive) AMR.

44 r CAABMR (C4+/DSA- or C4d-/DSA+) and TG with definite CAABMR (C4d+/DSA+) were 63%, 20%, and 17%, resp

45 Suspicious and definite CAABMR showed a similar prognosis, significantl

46 during 24 months' follow-up) and absence of definite cancer (absence of any histology result definit

47 dence interval, 53.2-64.0), leading to 50.8% definite CAP and 28.8% excluded CAP, and 80% of modifica

48 Acetaldehyde is an ethanol-derived definite carcinogen that causes oesophageal squamous cel

49 vascular magnetic resonance findings were of definite cardiac amyloidosis in 2, but could be explaine

50 ly, Low Positive NMDAR-Abs were present in 7 Definite cases as well as in 13 Possible cases.

51 Definite cases had laboratory evidence of Zika virus inf

52 the relevance of CSF t-PrP to distinguish 30 definite cases of AD from 52 definite cases of CJD.

53 distinguish 30 definite cases of AD from 52 definite cases of CJD.

54 were described; 22 had evidence supporting a definite causal association with TMA.

55 A definite cause of pancreatitis is due to the antiepilept

56 l factors have been implicated as risks, but definite causes remain unknown.

57 farcts from small-vessel disease, and "other definite" causes and worse onset NIHSS scores.

58 socratic separation conditions at the CPA of definite CCD fractions were developed.

59 produced an immediate drop in abuse rates, a definite ceiling effect appeared over time, beyond which

60 s admissions, 101 had possible, probable, or definite cellulitis or soft tissue infections.

61 reatment strategy, defined as the absence of definite cerebrospinal fluid (CSF) sterilization or rela

62 y associated with histologically probable or definite cirrhosis (Ishak stage S6; odds ratio [OR]: 2.1

63 ium was associated with an increased rate of definite CKD (0 prescriptions: hazard ratio [HR] = 1.09,

64 Possible CKD, definite CKD, and end-stage CKD (defined as long-term di

65 ric tube thrust after nitrates medication in definite clinical case supported by known functional dis

66 ized controlled trials are needed to provide definite clinical evidence.

67 -physician-based survey, we investigated the definite clinical impact of (68)Ga-DOTATATE PET/CT on ma

68 esting in cardiac arrest survivors without a definite clinical phenotype is unclear.

69 munoglobulin treatment regimen was given, no definite clinical response was seen.

70 hiolate ligands behave as giant molecules of definite composition and structure; however, their rigor

71 ific lipid variants is needed before drawing definite conclusions about causality based on Mendelian

72 Although no definite conclusions can be drawn by this extremely rare

73 However, publication biases preclude any definite conclusions for prevention of infection.

74 ed using harmonized UFP measurements to draw definite conclusions on health effects of UFP.

75 More research is needed to draw definite conclusions on the possible effect of donor age

76 proBNP levels, this trial was unable to draw definite conclusions regarding the incremental value of

77 Even though the small sample size limits definite conclusions, our cross-sectional study showed s

78 probable criteria or underwent conversion to definite criteria over time.

79 ce of clinical recurrence within 24 month' ("definite cure").

80 These interactions followed a definite cyclical pattern of occupancy (mostly G1) and r

81 Adjudicated definite diabetic ketoacidosis occurred in four (1%) pat

82 with final diagnosis of PTB, 263 (71.8%) had definite diagnosis and 92 cases had probable diagnosis.

83 these lesions sometimes are not enough for a definite diagnosis and immunohistochemical studies may b

84 Without knowledge that the definite diagnosis for all the lesions was melanoma, 2 d

85 The definite diagnosis is incidental in most cases.

86 Although the definite diagnosis is routinely made ex vivo by histopat

87 The definite diagnosis of food allergy relies-as in humans-o

88 ldren, and 7 children <5 years of age) had a definite diagnosis of MFS and were included in the study

89 All participants had a probable or definite diagnosis of sCJD and had at least 2 MRI studie

90 Patients aged >/= 3 years with a definite diagnosis of TSC and increasing SEGA lesion siz

91 ing a 75-g oral glucose tolerance test had a definite diagnosis of type 2 diabetes or received antidi

92 e for Roifman syndrome (RNU4ATAC) provided a definite diagnosis.

93 a median (IQR) of 41 (30-57) days and until definite discharge planning.

94 The incidence rates of any definite drug-induced ALF and acetaminophen-induced ALF

95 riteria, 17 patients (1.9-fold increase) had definite endocarditis.

96 There is no definite etiology for this condition.

97 unted for 61 of the 104 patient reports with definite evidence (quinine, 34; cyclosporine, 15; tacrol

98 Our research presents the first definite evidence for the auditory system prioritizing t

99 There are no definite explanations as to the variable sensitivity to

100 imaging (kappa = 0.266-0.439); and fair for definite extraprostatic extension on T2-weighted images

101 ore obese participants qualified as probable/definite FH (0.58%, 1 in 172) than nonobese (0.31%, 1 in

102 The prevalence of probable to definite FH according to DLC criteria was 27.2% (95% CI:

103 based presequencing criteria for probable or definite FH diagnosis.

104 estimated overall US prevalence of probable/definite FH was 0.40% (95% confidence interval, 0.32-0.4

105 valence and confidence intervals of probable/definite FH were calculated for the overall population a

106 CI: 19.1% to 37.0%; n = 28) with possible to definite FH.

107 Sometimes, no definite filling defect could be found by cholangiogram

108 From these results, we propose (i) there is definite functional interaction of the linker both with

109 Intragrader repeatability was high for both definite fungus (kappa: 0.88-0.95) and definite Acantham

110 rader agreement was good: kappa was 0.88 for definite fungus; kappa was 0.72 for definite Acanthamoeb

111 g for computational efficiency, and, without definite genotype calls, the prephasing task becomes com

112 There are no definite guidelines for therapy of these aneurysms.

113 Definite HAM/TSP developed in 5 (1.47%) patients.

114 Of 414 subjects, 76 had definite HAM/TSP, 87 had possible or probable HAM/TSP, a

115 Subjects with definite HF, as defined by the Framingham criteria, were

116 91 patients, and 899 were considered to have definite, highly likely, or probable DILI.

117 LAM LFA had a sensitivity of 75% for definite histopathological TBM, ELISA a sensitivity of 4

118 cases, (18)F-FDG PET/CT changed possible to definite IE (26%) and in 45 of 70 cases changed possible

119 Cases and controls had definite IE caused either by oral streptococci or nonora

120 hort of consecutively enrolled patients with definite IE from 29 centers in 16 countries.

121 ghty-five patients (13%) were diagnosed with definite IE within the 12 weeks of initial presentation

122 Two hundred thirty-three cases of definite IIH were identified across 8 sites.

123 stic criteria (2013) were applied to confirm definite IIH.

124 oncentration selected for the addition had a definite impact on the results.

125 CAP was initially classified as definite in 143 patients (44.8%), probable or possible i

126 edle; LBN) have been associated with low but definite incidence of major complications with EA.

127 agnosed, early-stage breast cancer who had a definite indication for chemotherapy, any nodal status,

128 ith a CHADS2=1 were reclassified as having a definite indication for OAC (CHA2DS2-VASc score >/=2).

129 nternational Registry included patients with definite infective endocarditis after TAVR from 47 cente

130 ensive-care unit was a composite endpoint of definite intensive-care-unit mortality, presumed intensi

131 rical structures of these molecules there is definite involvement in bonding of the formally core 5p

132 we recruited patients aged 45-85 years with definite IPF diagnosed prior to 3 years of screening fro

133 1-year all-cause mortality on patients with definite left-sided S. aureus PVIE and no history of inj

134 We included patients from ICE-PLUS with definite left-sided, non-cardiac device-related IE who w

135 hat information accumulates by moving across definite levels of evidence, carving out a single trajec

136 protein (RhoGAP) activity to be focused at a definite locus.

137 red (36 patients, 57%); in only two (3%) did definite MCS persist.

138 a control group comprising 15 patients with definite metallic stent thrombosis.

139 racterized by a microarchitecture built of a definite mineral assemblage with various organic matter

140 esicles the change in temperature displays a definite minimum, between decanol and tetradecanol, as a

141 o sc IFN beta-1a and not reaching clinically definite MS (clinically definite MS, CDMS (second attack

142 om a first demyelinating event to clinically definite MS in a phase III trial.

143 not associated with conversion to clinically definite MS over the 5-year follow-up (hazard ratio [HR]

144 reaching clinically definite MS (clinically definite MS, CDMS (second attack or sustained Expanded D

145 m clinically isolated syndrome to clinically definite MS, fractions of cortical and subcortical gray

146 nformation derived from review of nearly 200 definite MSA cases in the Mayo Clinic Brain Bank.

147 th a short conversion interval to clinically definite multiple sclerosis (MS) (fast converters (FC),

148 ted with subsequent conversion to clinically definite multiple sclerosis and disability.

149 ssociated with the development of clinically definite multiple sclerosis within 2 years (magnetizatio

150 antly steeper in those developing clinically definite multiple sclerosis within 2 years compared to t

151 ence of a second clinical attack (clinically definite multiple sclerosis) at months 36 and 60.

152 9 (51%) of 368 patients developed clinically definite multiple sclerosis.

153 in predicting the development of clinically definite multiple sclerosis.

154 , 39+/-17.2 years) were classified as having definite (n=13) or probable (n=3) DRESS.

155 or inhibitor 1 had a strong association with definite NASH compared to not NASH or borderline NASH in

156 on gene expression analysis, borderline and definite NASH were associated with abnormal immune funct

157 1.7% female, mean age 47.7 years), 58.0% had definite NASH, 55.5% had mild/no fibrosis (stage 0-1), a

158 europathic pain, 100% had probable and 95.2% definite neuropathic pain.

159 Twenty-five (44.6%) patients had a Definite NMDAR-Ab encephalitis (eight ovarian teratomas,

160 -of-treatment liver biopsy had resolution of definite non-alcoholic steatohepatitis compared with two

161 he primary outcome measure was resolution of definite non-alcoholic steatohepatitis with no worsening

162 s with NAFLD, 24% had borderline and 10% had definite nonalcoholic steatohepatitis (NASH).

163 Patients (n = 206) with definite NVAF receiving TEE were included for this prosp

164 lective bands in the 34 eyes with clinically definite ONHD, the minimum length of isolated hyperrefle

165 based on analysis of 34 eyes with clinically definite ONHD.

166 review, 62 (9.3%) were categorized as having definite or possible ALF, and 32 (51.6%) had a drug-indu

167 ween 1995 and 2013 who fulfilled criteria of definite or possible PNS without concomitant onconeural

168 st, and a significant LVEF drop, or death of definite or probable cardiac causes.

169 Because many definite or probable cases present normal head circumfer

170 One in five definite or probable cases presented head circumferences

171 Adults with definite or probable CIDP who responded to intravenous i

172 Definite or probable device thrombosis occurred in 31 pa

173 ) and the primary safety outcome measure was definite or probable device thrombosis.

174 398 patients (30.2%) with 67 of 398 having a definite or probable diagnosis (17%), including Long-QT

175 Of 720 patients evaluated, 278 received a definite or probable diagnosis and received long-term ma

176 diagnostic confirmation in a patient with a definite or probable diagnosis of multiple sclerosis.

177 ears), 904 participants (6.2%) experienced a definite or probable ischemic stroke.

178 ts adjudicated each event, categorizing each definite or probable MI as type 1 or type 2 and identify

179 e, 43-55 years]; 430 men and 141 women) with definite or probable MIs, 288 MIs (50.4%) were type 2 an

180 l fluid (CSF) samples from 239 patients with definite or probable prion disease and 100 patients with

181 ents in the bioresorbable scaffold group had definite or probable scaffold thromboses (one definite a

182 No definite or probable scaffold thrombosis was observed.

183 Definite or probable ST occurred in 92 (1.1%) of 8582 pa

184 onfidence interval [CI], 0.90-1.24; P=0.50), definite or probable stent thrombosis (RR, 1.26; 95% CI,

185 The pooled incidence of definite or probable stent thrombosis after BVS implanta

186 The coprimary endpoints were definite or probable stent thrombosis and major adverse

187 Definite or probable stent thrombosis was also significa

188 The risk of definite or probable stent thrombosis was significantly

189 y, no significant differences in the risk of definite or probable stent thrombosis were recorded acco

190 t reactivity, and subsequent adverse events (definite or probable stent thrombosis, all-cause mortali

191 ety endpoints were target lesion failure and definite or probable stent thrombosis, respectively.

192 The primary safety end point was definite or probable stent thrombosis.

193 The risk of definite or probable stent/scaffold thrombosis (RR, 3.22

194 The risk of definite or probable stent/scaffold thrombosis and very

195 rization, and the primary safety outcome was definite or probable stent/scaffold thrombosis.

196 ver, R-ZES and EES had similar risks of late definite or probable very late stent thrombosis (RR, 1.0

197 cohort 2 were diagnosed as having possible, definite, or end-stage CKD, respectively.

198 hanges and clinical symptoms progressed in a definite order.

199 (age 60.6 +/- 9.6 y; BMI 27.8 +/- 4.8) with definite osteophytes in one knee (earlyROA, n = 32) and

200 m of all identified markers were proposed as definite parameters for determination of roasting degree

201 y of postmortem samples from patients with a definite pathological diagnosis of Alzheimer disease, fr

202 al infiltrates were also noted in the liver, definite pathology was not seen in other tissues.

203 in 3/3 patients with tumours but in only 2/5 Definite patients, and none of the Possible or Unlikely

204 A definite pattern has not been found yet for patients not

205 The number of airways to measure for a definite percentage error of radicalWAPi10 was computed

206 s Control and Prevention case definition of "definite" pertussis.

207 se with operationally defined suspected PEs, definite PEs, and psychotic disorder.

208 bility of glaucoma suspect/POAG combined and definite POAG increased substantially when best-performi

209 une basis for the condition was assigned as 'Definite', 'Possible' or 'Unlikely'.

210 ported satisfaction or extreme satisfaction, definite preference for tofacitinib, and definite willin

211 Among those with definite primary glaucoma that had gonioscopy (n = 243),

212 boratory-confirmed cases were categorized as definite, probable, and not healthcare associated based

213 Definite, probable, and possible stent thrombosis appear

214 Cases were categorized as definite, probable, or possible according to strength of

215 January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Esc

216 The diagnostic strength was classified as definite, probable, or possible based on previously publ

217 CAP diagnosis probability (definite, probable, possible, or excluded) and therapeut

218 (50/151) and 17.9% (27/151) of patients had definite-, probable-, and non-TB respectively; 69.5% (10

219 tients treated with BVS had a higher risk of definite/probable ST compared with patients treated with

220 Rates of definite/probable ST were analyzed according to DAPT dis

221 : 0.51; 95% CI: 0.26 to 0.98; p = 0.043) and definite/probable stent thrombosis (1.3% vs. 4.8%; HR: 0

222 The primary outcomes of our analysis were definite/probable stent thrombosis (ST) and target lesio

223 ts (ZES 21.9% versus EES 21.6%, P=0.88), and definite/probable stent thrombosis (ZES 2.8% versus EES

224 he primary efficacy and safety outcomes were definite/probable stent thrombosis and clinically signif

225 Definite/probable stent thrombosis rates were low in bot

226 were rates of 1-year myocardial infarction, definite/probable stent thrombosis, target lesion revasc

227 Complex Semi-Definite Programming (SDP) is introduced as a novel appr

228 association network, Bayesian network, semi-definite programming-support vector machine (SDP-SVM), r

229 xture of racemized amino acids, we provide a definite proof that this primordial soup, when properly

230 ere unclassifiable including 21 (21.0%) with definite pulmonary tuberculosis, as they did not meet th

231 erves innervating the human upper limbs, the definite quantity of sensory and motor axons within this

232 Although definite reductions in maternal mortality remain uncerta

233 with DC and provided a conclusive diagnosis (definite/rejected) in 95% of cases.

234 Key inclusion criteria were a diagnosis of definite relapsing-remitting multiple sclerosis, exposur

235 patients (mean age 33.4 yrs) with clinically definite, relapsing-remitting MS and mild disability (ED

236 There was no definite relationship between practice volume and concor

237 The rates for definite reoperations were 1.3% (1.2% after ILM peeling

238 Children with both borderline and mild definite RHD are at substantial risk of progression.

239 Of those with mild definite RHD or borderline RHD, more advanced disease ca

240 Of children with moderate-to-severe definite RHD, 47.6% had echocardiographic progression (i

241 The prevalence of borderline or definite rheumatic heart disease was 10.2 (95% CI, 7.5-1

242 asmon interactions have been shown to have a definite role in light propagation through optical micro

243 to the Strasbourg criteria, 34 patients had definite Schnitzler syndrome, five had probable Schnitzl

244 y involved 598 participants with probable or definite sCJD followed up over 470 patient-years at a sp

245 The incidence of probable and definite ScT was 1.8% at 30 days and 3.0% at 12 months,

246 associated conditions and exposures seen in definite secondary pseudotumor cerebri syndrome included

247 n with primary pseudotumor cerebri syndrome, definite secondary pseudotumor cerebri syndrome patients

248 ins (IDPs) are a set of proteins that lack a definite secondary structure in solution.

249 otarolimus-eluting stents had lower rates of definite ST than SES and lower rates of myocardial infar

250 ut it has its own history, background, and a definite starting point.

251 structed by a measurement process by which a definite state of evidence is created from this indefini

252 Currently, major guidelines make no definite statement about postoperative UDCA prophylaxis

253 Definite steatohepatitis was divided into steatohepatiti

254 ularization, or Academic Research Consortium definite stent thrombosis (1.4% versus 2.1%; OR, 0.69; 9

255 point of all-cause mortality, restenosis, or definite stent thrombosis (hazard ratio, 0.65; 95% confi

256 re associated with lower rates of mortality, definite stent thrombosis (ST), and myocardial infarctio

257 ratio, 1.00; 95% CI, 0.84 to 1.19; P=0.98), definite stent thrombosis in 0.4% and 0.7%, respectively

258 .07 to 0.46), with a lower risk of very late definite stent thrombosis in the EES group (0.2% vs. 1.4

259 Rates of definite stent thrombosis occurred in 5 (0.4%) of the si

260 Definite stent thrombosis was lower with EES (0.4%) than

261 95% CI, 0.69 to 0.85; P<0.001); the rates of definite stent thrombosis were 0.8% and 1.2%, respective

262 ined ischemic endpoint of cardiac death, MI, definite stent thrombosis, and ischemic stroke (12 [4.0%

263 e of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical event

264 e of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical event

265 e of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical event

266 posite of death, myocardial infarction (MI), definite stent thrombosis, stroke, or Thrombolysis In My

267 due largely due to a lower risk of very late definite stent thrombosis.

268 , target vessel revascularization (TVR), and definite stent thrombosis.

269 Rs included cardiac death, reinfarction, and definite stent thrombosis.

270 was attributable to a lower risk of subacute definite stent thrombosis: 0.1% versus 0.6% (rate ratio,

271 cularization (9.8% versus 10.2%; P=0.97) and definite stent/scaffold thrombosis (2.7% versus 1.6%; P=

272 enosis, target lesion revascularization, and definite stent/scaffold thrombosis.

273 sting that the cholesterol rich domain has a definite stoichiometry and once this cholesterol concent

274 scaffold thromboses (one definite acute, one definite sub-acute, and one probable late), compared wit

275 The 61 SUDEP cases were categorized as definite SUDEP (n = 54), probable SUDEP (n = 5), and def

276 SUDEP (n = 54), probable SUDEP (n = 5), and definite SUDEP plus (n = 2).

277 Two deaths were definite SUDEP, and 1 was probable SUDEP.

278 ients with three or more core features and a Definite syndrome, but also in five patients classified

279 enables integration of TCR specificity into definite T cell lineage commitment.

280 al histology were the reference standard for definite TBP.

281 Cases of definite (the same eye was coded both times) and presume

282 Forty-eight patients with definite TSC (41 women; mean age, 35 years +/- 11 [stand

283 tation identification rate for patients with definite TSC was 85%, but only 29% for the ones with a p

284 om Greece have been analyzed, of whom 13 had definite TSC, whereas another 7 had a possible TSC diagn

285 Children were categorized as definite tuberculosis (culture positive), probable tuber

286 ement (kappa = 0.48) with 100% agreement for definite tuberculosis and moderate agreement for not tub

287 Of these, 165 (35.6%) were definite tuberculosis, and 299 (64.4%) were not tubercul

288 participants were classified as probable or definite tuberculous meningitis by uniform case definiti

289 5% CI 47-87; 16 of 23 cases) for probable or definite tuberculous meningitis compared with 43% (23-66

290 ts in these trials represented patients with definite UIP and a large subgroup of patients with possi

291 ent increase in pediatric nephrolithiasis, a definite underlying cause remains elusive.

292 f median SWS in discerning no, equivocal, or definite urinary tract obstruction (area under the ROC c

293 scintigraphic evidence of no, equivocal, or definite urinary tract obstruction (P > .5) or for media

294 ng electrons and muons have not revealed any definite violation of this assumption, recent studies of

295 % CI, 100%-100%]) and 27 of 28 patients with definite viral infection were classified as viral (speci

296 6 (69%) required intensive care, and 92 with definite viral infection, of whom 32 (35%) required inte

297 tion as having definite bacterial infection, definite viral infection, or indeterminate infection.

298 130 children, with 23 definite bacterial, 28 definite viral, and 79 indeterminate infections; median

299 patients (42 DES and 19 BMS) presenting with definite VLST.

300 on, definite preference for tofacitinib, and definite willingness to use tofacitinib again on the IBD